BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 15546400)

  • 1. Cytokines in cancer immunity and immunotherapy.
    Smyth MJ; Cretney E; Kershaw MH; Hayakawa Y
    Immunol Rev; 2004 Dec; 202():275-93. PubMed ID: 15546400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons, immunity and cancer immunoediting.
    Dunn GP; Koebel CM; Schreiber RD
    Nat Rev Immunol; 2006 Nov; 6(11):836-48. PubMed ID: 17063185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting cancers from within: augmenting tumor immunity with cytokine therapy.
    Pellegrini M; Mak TW; Ohashi PS
    Trends Pharmacol Sci; 2010 Aug; 31(8):356-63. PubMed ID: 20561689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.
    van der Most RG; Currie AJ; Robinson BW; Lake RA
    Cell Death Differ; 2008 Jan; 15(1):13-20. PubMed ID: 18007666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy of malignant diseases].
    Dorval T; Michon J; Tartour E; Fridman WH
    Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation as a tumor promoter in cancer induction.
    Philip M; Rowley DA; Schreiber H
    Semin Cancer Biol; 2004 Dec; 14(6):433-9. PubMed ID: 15489136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The resolution of inflammation and cancer.
    Rodriguez-Vita J; Lawrence T
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):61-5. PubMed ID: 20022797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine therapy for cancer.
    Kim-Schulze S; Taback B; Kaufman HL
    Surg Oncol Clin N Am; 2007 Oct; 16(4):793-818, viii. PubMed ID: 18022545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and immuno-gene therapy for solid tumors.
    Li CY; Huang Q; Kung HF
    Cell Mol Immunol; 2005 Apr; 2(2):81-91. PubMed ID: 16191413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biotherapy of cancer].
    Subirá ML; Brugarolas A
    Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and immune response in the tumor microenvironment.
    Mocellin S; Wang E; Marincola FM
    J Immunother; 2001; 24(5):392-407. PubMed ID: 11696695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
    Mumm JB; Oft M
    Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated bacteria as effectors in cancer immunotherapy.
    Al-Ramadi BK; Fernandez-Cabezudo MJ; El-Hasasna H; Al-Salam S; Attoub S; Xu D; Chouaib S
    Ann N Y Acad Sci; 2008 Sep; 1138():351-7. PubMed ID: 18837910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.
    Bronte V; Cingarlini S; Marigo I; De Santo C; Gallina G; Dolcetti L; Ugel S; Peranzoni E; Mandruzzato S; Zanovello P
    Immunol Invest; 2006; 35(3-4):327-57. PubMed ID: 16916757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matricellular proteins at the crossroad of inflammation and cancer.
    Sangaletti S; Colombo MP
    Cancer Lett; 2008 Aug; 267(2):245-53. PubMed ID: 18471960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer?
    Llera AS; Girotti MR; Benedetti LG; Podhajcer OL
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):67-76. PubMed ID: 20006533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.
    Mantovani A; Sica A; Allavena P; Garlanda C; Locati M
    Hum Immunol; 2009 May; 70(5):325-30. PubMed ID: 19236898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.